Choisissez la langue de votre document :
- bg - български
- es - español
- cs - čeština
- da - dansk
- de - Deutsch
- et - eesti keel
- el - ελληνικά
- en - English
- fr - français
- ga - Gaeilge
- hr - hrvatski
- it - italiano
- lv - latviešu valoda
- lt - lietuvių kalba
- hu - magyar
- mt - Malti
- nl - Nederlands
- pl - polski
- pt - português
- ro - română
- sk - slovenčina
- sl - slovenščina
- fi - suomi
- sv - svenska
|
| Procedure : 2008/0256(COD) |
|
Document stages in plenary
| Document selected : A7-0290/2010 | ||||||
Texts tabled : A7-0290/2010 |  | Debates : PV 22/11/2010 - 17CRE 22/11/2010 - 17 |  | Votes : PV 24/11/2010 - 8.3Explanations of votes Explanations of votes Explanations of votes |  | Texts adopted : P7_TA(2010)0429 |
| Verbatim report of proceedings | |
| Wednesday, 24 November 2010 - Strasbourg | OJ edition |
|
8.3. Information on medicinal products (Community code relating to medicinal products) (
| Legal notice - Privacy policy |